Stetson, Daniel
AstraZeneca (United States)
3 papers on CoChatORCID 0000-0002-3961-2739
Most cited papers
- Verified
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
Thress, K. S., Paweletz, C. P., Felip, E., Cho, B. C., Stetson, D., Dougherty, B., Lai, Z., Markovets, A., Vivancos, A., Kuang, Y., et al. (2015) · Nature Medicine
Lung Cancer Treatments and MutationsCancer Genomics and Diagnostics
Cited by 1,589
- Verified
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA
Abbosh, C., Frankell, A. M., Harrison, T., Kisistok, J., Garnett, A., Johnson, L., Veeriah, S., Moreau, M., Chesh, A., Chaunzwa, T. L., et al. (2023) · Nature
Cancer Genomics and DiagnosticsLung Cancer Diagnosis and Treatment
Cited by 382
- Verified
Circulating tumor DNA and late recurrence in high-risk hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer
Lipsyc-Sharf, M., de Bruin, E. C., Santos, K., McEwen, R., Stetson, D., Patel, A., Kirkner, G. J., Hughes, M. E., Tolaney, S. M., Partridge, A. H., et al. (2022) · Journal of Clinical Oncology
Cancer Genomics and DiagnosticsBRCA gene mutations in cancer
Cited by 152
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free